|
|
|
| |
|
CommentsNew process would make anti-malarial drug less costlyPosted by American Chemical Society on May 23, 2012 at 01:59 PM
Organic Process Research & Development Scientists are reporting development of a new, higher-yield, two-step, less costly process that may ease supply problems and zigzagging prices for the raw material essential for making the mainstay drug for malaria. That disease sickens 300-500 million people annually and kills more than 1 million. The report on the process, which uses readily available substances and could be easily implemented by drug companies, appears in ACS’ journal Organic Process Research & Development. More...Post a Comment on: New process would make anti-malarial drug less costlyCommenting is not available in this channel entry. Next entries comments: Hazelnuts: New source of key fat for infant formula that’s more like mother’s milk Previous entries comments: Beetle-infested pine trees contribute more to air pollution and haze in forests Note from the Editor: This section is for comments from readers of canadafreepress.com. Please don't assume that Canada Free Press agrees with or endorses any particular comment just because we let it stand. A reminder: Anyone who fails to comply with our terms of use may lose his or her posting privilege. |
|
